Trial Profile
A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study Designed to Compare the Safety and Pharmacokinetics of Orally Administered Superoxide Dismutase Mimetic GC4702 With Intravenously Administered Superoxide Dismutase Mimetic GC4419 (Part 1), With Assessment of Food Effect (Part 2), in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2018
Price :
$35
*
At a glance
- Drugs GC 4702 (Primary) ; Avasopasem manganese
- Indications Stomatitis
- Focus Adverse reactions
- Sponsors Galera Therapeutics
- 02 Apr 2017 New trial record